
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with ADHD from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/adhd/topic/23052/</link>
        <description>Articles tagged with ADHD from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business Briefs: Kantar Media, Janssen, Eli Lilly, Boehringer Ingelheim, Sanofi, Aveo</title>
          <description>Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140.</description>
          <link>http://www.mmm-online.com/business-briefs-kantar-media-janssen-eli-lilly-boehringer-ingelheim-sanofi-aveo/article/296505/</link>
          <pubDate>Wed, 05 Jun 2013 17:47:38 GMT</pubDate>
          <itunes:summary>Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Shire, AthenaHealth, GSK, Novartis</title>
          <description>Shire expands its pipeline yet again, AthenaHealth stretches its HCP-patient reach, FDA delays GSK&apos;s bird-flu vaccine, Novartis wins approval for cystic fibrosis inhaler</description>
          <link>http://www.mmm-online.com/business-briefs-shire-athenahealth-gsk-novartis/article/285898/</link>
          <pubDate>Mon, 25 Mar 2013 16:00:24 GMT</pubDate>
          <itunes:summary>Shire expands its pipeline yet again, AthenaHealth stretches its HCP-patient reach, FDA delays GSK&apos;s bird-flu vaccine, Novartis wins approval for cystic fibrosis inhaler</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Gilead, Shire, The Medicines Co., HHS</title>
          <description>HHS wants input for its TXT4Tots childhood advice program, Gilead releases some Hep. C clinical trial data, and Shire settles with the DOJ over disputed marketing practices.</description>
          <link>http://www.mmm-online.com/business-briefs-gilead-shire-the-medicines-co-hhs/article/278976/</link>
          <pubDate>Mon, 04 Feb 2013 19:21:27 GMT</pubDate>
          <itunes:summary>HHS wants input for its TXT4Tots childhood advice program, Gilead releases some Hep. C clinical trial data, and Shire settles with the DOJ over disputed marketing practices.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Shire launches ADHD tech challenge</title>
          <description>Taking a page from Sanofi, Shire is preparing to launch a developer challenge &quot;to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood.&quot;</description>
          <link>http://www.mmm-online.com/shire-launches-adhd-tech-challenge/article/276371/</link>
          <pubDate>Wed, 16 Jan 2013 21:30:44 GMT</pubDate>
          <itunes:summary>Taking a page from Sanofi, Shire is preparing to launch a developer challenge &quot;to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood.&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  